Levamisole toxicity: Difference between revisions
(→Workup) |
|||
| Line 35: | Line 35: | ||
==See Also== | ==See Also== | ||
*[[Cocaine]] | *[[Cocaine]] | ||
*[[Drug rash]] | |||
==External Links== | ==External Links== | ||
Revision as of 17:10, 29 June 2016
Background
- An antihelminthic and immunomodulator that has been withdrawn from the U.S. and Canadian markets, due to the risk of serious side effects
- Increasingly used as a cutting agent in cocaine sold around the globe
- 69% of DEA seized cocaine contained levamisole (2009)[1]
- Results in Levamisole induced necrosis syndrome[2]
Clinical Features
- Agranulocytosis/Thrombocytopenia
- Typically neutropenia
- Tends to reverse spontaneously when discontinued
- Levamisole induced necrosis syndrome
- Necrotic patches anywhere on skin (especially ears and legs)
- Leukoencephalopathy
- Seen when used as a pharmaceutical in past
- No cases described associated with cocaine adulteration
Differential Diagnosis
Diagnosis
- CBC
Management
- Neutropenia
- Consider neupogen
- Observation for neutropenic fever
- Necrosis
- Aggressive supportive care
- Burn care if significant necrosis
- Avoid cocaine re-exposure
- 27% of patients had symptom recurrence with cocaine re-exposure[3]
Disposition
Admission
See Also
External Links
References
- ↑ Larocque, L. Hoffman, R. Clinical Toxicology: Levamisole in cocaine: Unexpected news from an old acquaintance. (2012), 50, 231-234
- ↑ http://www.ncbi.nlm.nih.gov/pubmed/20668440
- ↑ Larocque, L. Hoffman, R. Clinical Toxicology: Levamisole in cocaine: Unexpected news from an old acquaintance. (2012), 50, 231-234